English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Autism spectrum disorder (ASD) affects 2% of children, and is characterized by impaired social and communication skills together with repetitive, stereotypic behavior. The pathophysiology of ASD is complex due to genetic and environmental heterogeneity, complicating the development of therapies and making diagnosis challenging. Growing genetic evidence supports a role of disrupted Ca 2+  signaling in ASD. Here, we report that patient-derived fibroblasts from three monogenic models of ASD—fragile X and tuberous sclerosis TSC1 and TSC2 syndromes—display depressed Ca 2+  release through inositol trisphosphate receptors (IP 3 Rs). This was apparent in Ca 2+  signals evoked by G protein-coupled receptors and by photoreleased IP 3  at the levels of both global and local elementary Ca 2+  events, suggesting fundamental defects in IP 3 R channel activity in ASD. Given the ubiquitous involvement of IP 3 R-mediated Ca 2+  signaling in neuronal excitability, synaptic plasticity, gene expression and neurodevelopment, we propose dysregulated IP 3 R signaling as a nexus where genes altered in ASD converge to exert their deleterious effect. These findings highlight potential pharmaceutical targets, and identify Ca 2+  screening in skin fibroblasts as a promising technique for early detection of individuals susceptible to ASD.

Shared functional defect in IP3R-mediated calcium signaling in diverse monogenic autism syndromes